Expression of PD-L1 and PD-L2, the ligands of the T-cell suppressive immune checkpoint receptor, PD-1, has been implicated in immune evasion resulting in recurrence or metastasis of HNSCC. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.